SunTrust Robinson Humphrey analyst Edward Nash downgraded Adverum Biotechnologies (NASDAQ: ADVM) from Buy to Hold with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE